Regulatory Affairs Syndicator

United Press International - GlaxoSmithKline’s Requip, a Parkinson’s drug that emerged as the market leader for RLS, brought increased attention to the disorder when the Food and Drug Administration approved it for the condition last year. However, Requip goes off patent in …

MSN MoneyCentral - FORT LEE, N.J. (AP) - Specialty drug maker Alpharma Inc. said Monday the Food and Drug Administration approved a new dosage level for Kadian, a pain killer. The drug, Alpharma’s only marketed product, was approved for an 80-milligram dose. It is …

Another sign of systemic conflicts of interest in our health care system. The Former Commissioner of the FDA, Lester M. Crawford,was charged with conflicts of interest.
Comment

One in five adults has a little hole in the heart. Most will never know it. But the defect may play a role in certain strokes and severe migraines, leading thousands to get devices implanted to seal it shut.
Comment

MSN MoneyCentral - Food and Drug Administration said faropenem medoxomil, an antibiotic, isn’t ready to market. Replidyne submitted a new drug application for faropenem medoxomil in December for the treatment of sinusitis, pneumonia, bronchitis and skin infections. The …

New York City’s Board of Health will hold its first public hearing on a proposal to make New York the first U.S. city to ban restaurants from serving food containing artificial trans fats.
Comment

Albany Molecular Research, Inc. has selected a compound from its proprietary oncology research program for advanced preclinical testing, with the goal of submitting an Investigational New Drug Application to …
Comment

United Press International - The focus of coming up with a drug that has the same effects as resveratrol is not to extend life but rather to develop therapies for diseases since the Food and Drug Administration doesn’t recognize aging as a problem. However, if a drug can retard …

By Laura MacInnisGENEVA - Drugs showing promise against virulent new strains of tuberculosis should have their regulatory approval fast-tracked because existing medicines are ineffective, Medicins Sans …
Comment

Fogarty International Center (FIC), Fogarty International Center Funds 10 Awards for ?Framework Programs?, October 30, 2006

Fogarty International Center (FIC), Fogarty International Center Funds 10 Awards for ?Framework Programs?, October 30, 2006

MSN MoneyCentral - Assuming toxicity and safety pharmacology tests go well, the company expects to submit an Investigational New Drug Application to the U.S. Food and Drug Administration in late 2007. FDA approval of the application would allow for Phase I human …

Genta Inc. said Monday the Food and Drug Administration will take another 90 days to review its marketing application for the cancer drug Genasense after the drug developer presented the agency with additional data.

Office of the Director (OD) and Office of Research on Women’s Health (ORWH), NIH Announces Awards in Chronic Fatigue Syndrome Research, October 30, 2006

Office of the Director (OD) and Office of Research on Women’s Health (ORWH), NIH Announces Awards in Chronic Fatigue Syndrome Research, October 30, 2006